Uterine sarcomas: clinical practice guidelines for diagnosis, treatment, and follow-up, by Spanish group for research on sarcomas (GEIS).

Ther Adv Med Oncol · 2023 · PMC10052607 · PMID 37007636

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

showed a trend to a better OS with adjuvant progestin, with a median of 94 months versus 72 months in those who did not receive this treatment. 41 Despite the lack of prospective data, due to the consistent reduction in the recurrence rate observed in retrospective studies, adjuvant hormonal treatment could be recommended in LG-ESS [IVB].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.